Hsbc Holdings PLC Oncorus, Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.24 - $0.76 $7 - $24	32 Added 0.12%	26,452 $6,000
Q2 2022 Aug 11, 2022	BUY	$1.04 - $1.86 $4,811 - $8,604	4,626 Added 21.23%	26,420 $34,000
Q1 2022 May 16, 2022	BUY	$1.44 - $5.62 $31,383 - $122,482	21,794 New	21,794 $39,000
Q1 2021 May 14, 2021	SELL	$11.89 - $35.55 $75,085 - $224,498	-6,315 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.0 - $35.15 $94,725 - $221,972	6,315 New	6,315 $204,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.